1. China Stocks

  2. •

    Consumer non-durables

  3. •

    Food: specialty/candy
Baolingbao Biology Co., Ltd. Class A

Baolingbao Biology Co., Ltd. Class A

SSZSE:002286
8.30
CNY
+0.06
(+0.73%)
0.38EPS
21.84P/E
3.14BMarket Cap
Oct 29Next Earn
Baolingbao Biology Co., Ltd. Class A
SZSE:002286
(Shenzhen Stock Exchange)

Recent

price

8.30

P/E

ratio

21.84

div

yld

0.98%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
2.65
3.5
3.63
2.63
2.4
3.21
3.63
4.17
4.83
5.12
5.77
7.41
7.33
7.01
6.48
7.49
7.58
Revenue per Share
0.16
0.2
0.25
0.12
0.06
0.11
0.13
0.13
0.12
0.1
0.14
0.54
0.36
0.15
0.3
0.41
0.38
Basic EPS, GAAP
-0.49
0.14
0.1
-0.18
-0.45
-0.33
0.03
-0.36
-0.11
0.17
0.75
0.3
-0.6
0.36
0.16
0.19
- -
Free Cash Flow per Basic Share
0.09
0.05
0.08
0.1
0.03
0.05
0.07
0.1
0.17
0.12
0.07
0.1
0.14
0.14
0.15
0.09
0.08
Dividend per Share
2.6
2.81
3.04
3.88
3.92
4
4.08
4.12
4.17
4.24
4.33
4.88
5.39
5.35
5.52
5.87
6.11
Book Value per Share
2.2
2.41
2.61
3.58
3.62
3.64
3.69
3.74
3.8
3.88
3.97
4.53
5.05
5.02
5.2
5.57
5.81
Tangible Book Value per Share
271
272
269
343
380
372
380
382
358
352
356
373
370
360
371
367
374
Basic Weighted Avg Shares
721
951
978
901
911
1,196
1,377
1,593
1,730
1,805
2,055
2,765
2,713
2,524
2,402
2,751
2,835
Sales/Revenue/Turnover
8.53
7.6
8.39
2.87
-0.29
2.14
2.72
3.55
4.13
4.18
3.54
8.4
6.18
3.65
6.73
6.86
6.53
Operating Margin (%)
28
38
45
48
50
56
78
77
84
98
96
105
106
123
120
120
- -
Depreciation Expense
43
56
69
41
23
41
49
50
43
35
50
202
133
54
111
151
141
Net Income, GAAP
15.38
15.52
15.29
14.7
13.09
14.35
15.78
14
18.78
23.72
16.38
14.85
15.01
17.12
15.22
15.29
15.57
Effective Tax Rate (%)
5.94
5.86
7.02
4.56
2.5
3.42
3.58
3.12
2.48
1.95
2.43
7.29
4.91
2.14
4.63
5.48
4.98
Profit Margin (%)
113
57
106
592
377
222
235
208
-58
47
49
195
236
209
234
430
444
Working Capital
24
- -
- -
- -
- -
- -
- -
- -
11
11
12
27
171
38
1
1
41
LT Debt
703
761
821
1,435
1,448
1,478
1,508
1,525
1,542
1,567
1,599
1,813
2,004
1,983
2,042
2,234
2,326
Total Equity
3.6
5.58
6.48
2.04
0.73
2.01
2.58
2.91
2.29
1.72
2.6
9.9
5.77
2.22
5.71
6.49
5.67
Return on Invested Capital (%)
6.05
7.19
8.17
3.74
1.7
3.04
3.34
3.29
3.47
2.86
3.11
10.63
6.59
3.04
5.32
6.79
5.98
Return on Capital (%)
6.27
7.62
8.69
3.64
1.58
2.8
3.31
3.28
2.8
2.27
3.15
11.81
6.98
2.71
5.52
7.05
6.4
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
115
217
137
LT Borrowings
- -
- -
40
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
381
381
381
Market Capitalization
3,402
3,665
3,140

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
914
1,021
1,041
Cash, Cash Equivalents & STI
277
286
313
Accounts Receivable, Net
268
327
340
Inventories
322
325
324
Total Current Liabilities
485
570
597
Payables & Accruals
- -
- -
- -
ST Debt
115
217
137
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.32%
7.04%
9.41%
Free Cash Flow
-180.76%
-109.69%
19.18%
Net Income, GAAP
38.35%
70.47%
35.5%
Sales/Revenue/Turnover
9.3%
7.09%
14.54%
Total Cash Common Dividend
13.12%
11.74%
-42.27%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
551
634
648
568
2,402
2025
685
714
- -
625
2,751
2026
748
748
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
0.12
0.09
0.03
0.3
2025
0.14
0.11
- -
0.04
0.41
2026
0.14
0.08
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
0.01
0.01
0.04
0.15
2025
0.01
0.07
- -
- -
0.09
2026
- -
0.01
- -
- -
- -
Similar Companies
PepsiCo, Inc. (NASDAQ:PEP)
Britannia Industries Ltd (NSE:BRITANNIA)
Tata Consumer Products Limited (NSE:TATACONSUM)
The Hershey Company (NYSE:HSY)
Mondelez International, Inc. (NASDAQ:MDLZ)
Ulker Biskuvi Sanayi A.S. (BIST:ULKER)
Business
Baolingbao Biology Co., Ltd. (002286.SZ) researches, develops, manufactures and sells functional sugars and related ingredients primarily from corn in China and internationally; its core products include prebiotics such as isomaltooligosaccharide, galacto-oligosaccharide, fructooligosaccharide and xylooligosaccharide; dietary fibers including polydextrose and resistant dextrin; sugar alcohols and sweeteners such as erythritol, allulose, trehalose, crystalline fructose and maltose; starch sugars comprising maltodextrin, glucose syrup, high fructose corn syrup, solid and liquid starch sugar series; and byproducts like corn steep liquor, corn gluten meal and modified starches, which serve applications in dairy, beverages, snacks, health supplements, confectionery, daily chemicals and animal nutrition. Founded in 1997 and headquartered in Yucheng, Shandong Province, China, the company, a national high-tech enterprise and manufacturing single champion, listed on the Shenzhen Stock Exchange A-shares in 2009 and operates as a global provider of functional health solutions with exports to international markets. In 2025, Baolingbao Biology won the iSEE global innovation award at Foodaily for its high-purity human milk oligosaccharide Supmos production technology and showcased products prominently at FIC 2025; the company also reported 2024 net profit exceeding CNY100 million with over 100% growth and improved gross margins.